Quantum Biopharma Class B Subordinate Voting Shares
QNTM
8 hedge funds and large institutions have $126K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
953% more capital invested
Capital invested by funds: $12K → $126K (+$114K)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
0.01% more ownership
Funds ownership: 0% → 0.01% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$89.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$11K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.86K |
| 4 |
SIM
Sonora Investment Management
Tucson,
Arizona
|
+$937 |
| 5 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
+$234 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$234 |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$234 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WS
1
Wedbush Securities
Los Angeles,
California
| $95K | +$89.5K | +382 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $12K | +$11K | +47 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $9K | +$5.86K | +25 | +227% |
|
4
Bank of Montreal
Toronto,
Ontario, Canada
| $6K | – | – | – |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $3.04K | -$234 | -1 | -8% |
|
|
SIM
6
Sonora Investment Management
Tucson,
Arizona
| $1K | +$937 | +4 | +200% |
|
|
7
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | -$234 | -1 | -50% |
|
|
NC
8
NewSquare Capital
Newtown Square,
Pennsylvania
| – | +$234 | +1 | New |
|
QNTM Hedge Fund Activity: Q2 2020 in Review
8 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q2 2020, worth a combined $126K — up 953% from $12K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new QNTM positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Wedbush Securities, opening a new position worth an estimated $89.5K. The largest seller was Federation des caisses Desjardins du Quebec, cutting an estimated $234.
- 8 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q2 2020, up from 6 in Q1 2020.
- Funds reported $126K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q2 2020, up 953% quarter-over-quarter.
- 3 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q2 2020 and 1 closed out, a net change of +2 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q2 2020 was Wedbush Securities, an estimated $89.5K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q2 2020 was Federation des caisses Desjardins du Quebec, an estimated $234 sold.
Based on aggregated 13F filings for Q2 2020.